Xtant Medical Holdings, Inc. XTNT
At closeNov 3, 2026, 5:11 PM EST
After hours · Nov 3, 5:11 PM ET
- YTD
- -64.36%
- 1 year
- -65.68%
- Market cap
- 39.00M
- Revenue (ttm)
- 110.94M
- Profit margin
- -3.00%
- EPS (ttm)
- -0.08
- Shares out
- 139.01M
- Forward P/E
- -13.43
- YTD return
- -64.36%
- 1-year return
- -65.68%
- Volume
- 68.88K
- Avg volume
- 1.70M
- Open
- 0.2756
- Previous close
- 0.2784
- Day's range
- 0.2761 – 0.29
- 52-week range
- 0.27 – 0.85
- Beta
- 0.39
- Price target
- 2.25 (+709.4%)
2Y -0.2460 (-46.42%)
Key statistics
- Enterprise value
- 99.98M
- PEG ratio
- 0.00
- Price / sales
- 0.50
- Price / book
- 1.02
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 48.00%
- Free cash flow
- -28.14M
- Total cash
- 5.38M
- Total debt
- 34.99M
- Return on equity
- -8.77%
- Short % of float
- 0.41%
- 50-day average
- 0.467
- 200-day average
- 0.68755
Analyst view
- Target (low)
- 1.50
- Target (mean)
- 2.25
- Target (high)
- 3.00
- Strong buy0
- Buy2
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.02.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 12, 2024 | Sep 1, 2024 | 0.00 | -0.04 | — | — |
| Aug 8, 2024 | Jun 1, 2024 | 0.00 | -0.03 | — | — |
| May 15, 2024 | Mar 1, 2024 | 0.00 | -0.03 | — | — |
| Apr 1, 2024 | Dec 1, 2023 | 0.00 | -0.03 | — | — |
| Nov 9, 2023 | Sep 1, 2023 | 0.00 | 0.07 | — | — |
| Aug 1, 2023 | Jun 1, 2023 | 0.00 | -0.02 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 16, 2024 | BTIG | main | Buy | Buy |
| Dec 5, 2023 | BTIG | init | — | Buy |
| Jul 11, 2023 | Craig-Hallum | main | Buy | Buy |
| Apr 26, 2023 | Craig-Hallum | init | — | Buy |
| May 17, 2019 | Maxim Group | down | Buy | Hold |
| Dec 8, 2016 | Maxim Group | init | — | Buy |
About Xtant Medical Holdings, Inc.
Xtant Medical Holdings, Inc. provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, a growth factor enriched cellular bone matrix; and nanOss family of products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier. It also processes and distributes sports allografts for anterior and posterior cruciate ligament repairs, anterior cruciate ligament reconstruction, and meniscal repair; milled spinal allografts for cortical bone milled to desired shapes and dimensions; and traditional allografts for orthopedics, neurology, podiatry, oral/maxillofacial, genitourinary, and plastic/reconstructive applications. In addition, it offers Certex spinal fixation, Spider cervical plating, Streamline OCT, CervAlign, Axle interspinous fusion, Xpress minimally invasive pedicle screw, Fortex pedicle screw, Axle-X interspinous fusion, Streamline MIS spinal fixation, Streamline TL spinal fixation systems, and Silex sacroiliac joint fusion systems. Further, it provides Calix for cervical and thoracolumbar applications, as well as Irix-C Cervical Integrated Fusion, Irix-A Lumbar Integrated Fusion, Fortilink, and Irix-A Lumbar integrated fusion systems; Coflex device for lumbar spinal stenosis; and CoFix implant for back and disc pain. The company is headquartered in Belgrade, Montana.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- xtantmedical.com
News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session 
LUCID CAPITAL MARKETS Initiates Coverage On Xtant Medical Holdings with Buy Rating, Announces Price Target of $1 
12 Health Care Stocks Moving In Monday's After-Market Session - 12 Health Care Stocks Moving In Friday's After-Market Session
- 12 Health Care Stocks Moving In Friday's Intraday Session
- Xtant Medical Enters Exclusive Partnership With Henry Schein's Biohorizons To Distribute The Company's Allogeneic Growth Factor Technology Under The Prolifica Private Brand
Xtant Medical Announces Exclusive Partnership with BioHorizons to Expand Access to Xtant's Allogeneic Growth Factor into the Dental Market - 12 Health Care Stocks Moving In Tuesday's Intraday Session
Xtant Medical Holdings, Inc. (XTNT) Q2 2026 Earnings Call Transcript 
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Your note
Sign in to keep a note on XTNT — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BAKEWELL JOHN K | Director | Stock Award(Grant) | Aug 14, 2024 | 755,888 |
| BEESON JONN R. | Director | Stock Award(Grant) | Aug 14, 2024 | 1,374,660 |
| BRANDT KEVIN D | Officer | Stock Award(Grant) | Apr 2, 2024 | 1,000,070 |
| BROWNE SEAN E. | Chief Executive Officer | Stock Award(Grant) | Apr 2, 2024 | 2,306,990 |
| MCNAMARA ROBERT E | Director | Stock Award(Grant) | Aug 14, 2024 | 754,151 |
| MITCHELL-KELLER LORI D | Director | Stock Award(Grant) | Aug 14, 2024 | 353,124 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Orbimed Advisors LLC. | 52.60% | 73,114,592 | 29.47M | Sep 29, 2024 |
| Nantahala Capital Management, LLC | 8.20% | 11,394,000 | 4.59M | Sep 29, 2024 |
| Altium Capital Management, LP | 5.33% | 7,415,413 | 2.99M | Sep 29, 2024 |
| Vanguard Group Inc | 1.55% | 2,150,912 | 866.82K | Sep 29, 2024 |
| Juniper Investment Company, LLC | 0.95% | 1,318,944 | 531.53K | Sep 29, 2024 |
| Renaissance Technologies, LLC | 0.50% | 694,208 | 279.76K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.03% | 1,431,435 | 576.87K | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 0.52% | 719,477 | 289.95K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.21% | 292,915 | 118.04K | Oct 30, 2024 |
| Bridgeway Funds Inc-Ultra Small Company Market Fund | 0.20% | 279,000 | 112.44K | Sep 29, 2024 |
| Fidelity Total Market Index Fund | 0.08% | 114,332 | 46.08K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.05% | 69,348 | 27.95K | Oct 30, 2024 |